dinitrochlorobenzene has been researched along with Neoplasms in 57 studies
Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"A randomized trial of short-term Levamisole treatment was undertaken in a cancer population unresponsive to dinitrochlorobenzene (DNCB) to determine whether this agent increased delayed hypersensitivity." | 9.05 | Effect of short-term levamisole therapy on delayed hypersensitivity. ( Frydecka, I; Hirshaut, Y; Miké, V; Oettgen, HF; Passe, S; Pinsky, CM; Wanebo, HJ, 1980) |
"A randomized trial of short-term Levamisole treatment was undertaken in a cancer population unresponsive to dinitrochlorobenzene (DNCB) to determine whether this agent increased delayed hypersensitivity." | 5.05 | Effect of short-term levamisole therapy on delayed hypersensitivity. ( Frydecka, I; Hirshaut, Y; Miké, V; Oettgen, HF; Passe, S; Pinsky, CM; Wanebo, HJ, 1980) |
"A group of 220 patients with mycosis fungoides (MF) and other lymphomatous diseases was treated with sustained topical applications of dilute aqueous solutions of mechlorethamine hydrochloride for intervals ranging in excess of seven years." | 3.65 | Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results. ( Asbell, SO; Grekin, DA; Johnson, WC; Van Scott, EJ; Vonderheid, EC, 1977) |
"Delayed hypersensitivity to dinitrochlorobenzene (DNCB) was tested prior to radiation therapy in 206 patients with solid tumors." | 3.65 | Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors. ( Hazra, TA; Inalsingh, A; Parks, LC; Peeples, W, 1975) |
"Delayed hypersensitivity to DNCB and the inflammatory response to croton oil wereevaluated in 144 and 121 patients respectively, prior ro and 3 to 6 months following curative radiotherapy." | 3.65 | The effect of radial radiotherapy on delayed hypersensitivity and the inflammatory response. ( Bases, RE; Bosworth, JL; Ghossein, NA, 1975) |
"Delayed hypersensitivity, as determined by skin reactivity to 2-4 dinitrochlorobenzene (DNCB), was tested in 112 patients prior to their undergoing curative radiotherapy." | 3.65 | Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival. ( Bosworth, JL; Brooks, TL; Ghossein, NA, 1975) |
"Dinitrochlorobenzene skin testing is an assay that is easily performed and probably yields the most easily obtained significant prognostic information." | 2.36 | Assays of immunocompetence in the staging and prognosis of cancer. ( Robinson, JC, 1981) |
"Therefore, cancer surgery acts as immunotherapy because it removes the cancer cells that produce the immunodepression and allows the patient's immune response to recover." | 2.36 | Changing concepts of cancer surgery: surgery as immunotherapy. ( Morton, DL, 1978) |
"Patients with Hodgkin's disease tend to have depressed responses to both newly encountered and recall antigens." | 2.35 | Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. ( Burdick, JF; Herberman, RB; Wells, SA, 1975) |
"Testing of delayed hypersensitivity responses to recall antigens, newly encountered antigens and tumor antigens has contributed to the understanding of several immunologic factors in human neoplasia." | 2.35 | Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. ( Burdick, JF; Herberman, RB; Wells, SA, 1975) |
"Patients with solid tumors are more likely to be deficient only in the response to newly encountered antigens." | 2.35 | Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. ( Burdick, JF; Herberman, RB; Wells, SA, 1975) |
"Incidence of impaired skin reactions in cancer patients varied according to the tumor type." | 1.26 | Skin reactivity to dinitrochlorobenzene in cancer patients. ( Jassem, J; Serkies, K, 1980) |
"Many cancer patients have depressed immunologic competence, yet they frequently have cell-mediated immunity against tumor associated antigens." | 1.26 | Tumor immunology and immunotherapy. ( Herberman, RB, 1977) |
"The personal series consists of 140 cancer patients followed up over a period of some 3 years and submitted prior to the start of treatment to the DNCB skin test." | 1.26 | [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms]. ( Bianucci, P; De Rossi, O; Pastorino, G, 1979) |
"In 137 patients with different kinds of cancer and different cancer stage, cell-mediated immunity was investigated by DNCB (dinitrochlorobenzene) and tuberculin test." | 1.26 | Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy. ( Mazloumi, B; Missmahl, HP; Weber, W, 1978) |
"The concepts that human tumors elicit cell-mediated immune responses to tumor antigens are re-examined and modified; for example, cell-mediated immunity may be detectable only at certain stages of tumor growth." | 1.26 | Immunotherapy and human tumor immunology. ( Brosman, S; Fahey, JL; O'Toole, C; Ossorio, RC; Zighelboim, J, 1976) |
"The immune reactivity of patients with squamous carcinoma of the head and neck region was compared with that of patients with squamous carcinoma of the female pelvic organs and patients with adenocarcinomas, melanomas, and sarcomas." | 1.25 | Unique immunobiological aspects of head and neck squamous carcinoma. ( Chretien, PB, 1975) |
"Immunotherapy against cancer in animals has been established." | 1.25 | Immunotherapy of malignancy in humans. Current status. ( Eilber, FR; Holmes, EC; Morton, DL, 1975) |
"Six of 13 normal donors and 2 of 9 cancer patients had a fall in blood lymphocyte count which was below the lower limit of the range of change in control donors immediately following leukapheresis, but all returned to control range within 24 hours." | 1.25 | Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. I. Hematologic and immunologic parameters in vivo. ( Pilch, YH; Roth, JA; Silverstein, M; Veltman, LL; Waldman, SR, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 55 (96.49) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (1.75) | 24.3611 |
2020's | 1 (1.75) | 2.80 |
Authors | Studies |
---|---|
Alqarni, MH | 1 |
Foudah, AI | 1 |
Muharram, MM | 1 |
Labrou, NE | 1 |
Kirik, U | 1 |
Cifani, P | 1 |
Albrekt, AS | 1 |
Lindstedt, M | 1 |
Heyden, A | 1 |
Levander, F | 1 |
Cron, J | 1 |
Jansa, P | 2 |
Melita, P | 1 |
Belnome, NA | 1 |
Calbo, L | 1 |
Gorgone, S | 1 |
Palmeri, R | 1 |
Labruto, G | 1 |
Papalia, E | 1 |
Crescimanno, C | 1 |
Ahmed, AR | 1 |
Blose, DA | 1 |
Theilen, GH | 1 |
Hills, D | 1 |
Gogi, R | 1 |
Johri, A | 1 |
Hirshaut, Y | 1 |
Pinsky, CM | 3 |
Frydecka, I | 1 |
Wanebo, HJ | 3 |
Passe, S | 1 |
Miké, V | 2 |
Oettgen, HF | 2 |
Robinson, JC | 1 |
Bianucci, P | 2 |
Pastorino, G | 2 |
Brondi, P | 1 |
Yajnik, CS | 1 |
Mehta, MJ | 1 |
Sainani, GS | 1 |
Niwa, Y | 1 |
Niwa, H | 1 |
Kohmura, J | 1 |
Ou, DW | 1 |
Yokoyama, MM | 1 |
Jassem, J | 1 |
Serkies, K | 1 |
Barg, S | 1 |
Levin, M | 1 |
Rezzonico, R | 1 |
Reif, AE | 1 |
Southwick, PL | 1 |
Judd, KP | 1 |
Justo Alpañes, E | 1 |
Ledro Molina, D | 1 |
Sánchez Cousteau, JA | 1 |
Pantrigo Gordillo, C | 1 |
Rada Morgades, R | 1 |
Ramírez Martínez, R | 1 |
Silberio Aldebot, M | 1 |
Garrido Peralta, M | 1 |
Baskies, AM | 1 |
Chretien, PB | 3 |
Weiss, JF | 1 |
Makuch, RW | 1 |
Beveridge, RA | 1 |
Catalona, WJ | 2 |
Spiegel, HE | 1 |
Burdick, JF | 1 |
Wells, SA | 1 |
Herberman, RB | 2 |
Holmes, EC | 1 |
Eilber, FR | 2 |
Morton, DL | 5 |
Croft, CL | 1 |
Dodd, MJ | 1 |
Bates, SE | 1 |
Suen, JY | 1 |
Tranum, BL | 1 |
Grigorovich, NA | 1 |
Martysiuk, TI | 1 |
Monastyrnaia, PL | 1 |
De Rossi, O | 1 |
Beattie, EJ | 1 |
Weber, W | 1 |
Missmahl, HP | 1 |
Mazloumi, B | 1 |
Klein, E | 2 |
Rosner, D | 1 |
Holtermann, OA | 1 |
Stoll, HL | 1 |
Song, SY | 1 |
Tarpley, JL | 1 |
Twomey, PL | 1 |
Morris, DL | 1 |
Vonderheid, EC | 1 |
Van Scott, EJ | 1 |
Johnson, WC | 1 |
Grekin, DA | 1 |
Asbell, SO | 1 |
El-Domeiri, AA | 1 |
Zajaczkowski, J | 1 |
Sone, S | 1 |
Yata, K | 1 |
Tsubura, E | 1 |
Wanebo, H | 1 |
Oettgen, H | 1 |
Thompson, CD | 1 |
Whittingham, S | 1 |
Mackay, IR | 1 |
Khoo, SK | 1 |
Toh, BH | 1 |
Stagg, RJ | 1 |
Kopersztych, S | 1 |
Rezkallah, MT | 1 |
Miki, SS | 1 |
Naspitz, CK | 1 |
Mendes, NF | 1 |
Umanskiĭ, IuA | 1 |
Parmett, SR | 1 |
Bolton, PM | 1 |
Hazra, TA | 1 |
Parks, LC | 1 |
Inalsingh, A | 1 |
Peeples, W | 1 |
Ghossein, NA | 2 |
Bosworth, JL | 2 |
Bases, RE | 1 |
Roth, JA | 2 |
Nizze, JA | 1 |
Brooks, TL | 1 |
Waldman, SR | 1 |
Silverstein, M | 1 |
Veltman, LL | 1 |
Pilch, YH | 1 |
García-Sancho Martin, L | 1 |
Durán Sacristán, M | 1 |
García Blanco, A | 1 |
Conde Salazar, L | 1 |
Gorodilova, VV | 1 |
Karapetian, AS | 1 |
Mandrik, EV | 1 |
Radiuk, IV | 1 |
Simó-Camps, E | 1 |
Anguers, A | 1 |
Ma Vich, J | 1 |
Vidal-Ribas, A | 1 |
Sala, F | 1 |
Sarrias, R | 1 |
Gumma, J | 1 |
Gri, E | 1 |
Ma Puigdollers, J | 1 |
Fahey, JL | 1 |
Brosman, S | 1 |
Ossorio, RC | 1 |
O'Toole, C | 1 |
Zighelboim, J | 1 |
Takanami, I | 1 |
Nakayama, H | 1 |
O'Connell, TX | 1 |
Golub, SH | 1 |
Mandel, MA | 1 |
Kiehn, C | 1 |
8 reviews available for dinitrochlorobenzene and Neoplasms
Article | Year |
---|---|
Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
Topics: Adjuvants, Immunologic; Animals; Bacterial Toxins; BCG Vaccine; Cat Diseases; Cats; Cattle; Dinitroc | 1982 |
Assays of immunocompetence in the staging and prognosis of cancer.
Topics: Dinitrochlorobenzene; Female; Humans; Hypersensitivity, Delayed; Immunocompetence; Immunologic Techn | 1981 |
Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
Topics: Antigens; Antigens, Neoplasm; Arthus Reaction; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Coloni | 1975 |
Changing concepts of cancer surgery: surgery as immunotherapy.
Topics: Antibody Formation; Antigen-Antibody Complex; Dinitrochlorobenzene; Humans; Hypersensitivity, Delaye | 1978 |
Immunological skin testing and interpretation: a plea for uniformity.
Topics: Antigens; BCG Vaccine; Dinitrochlorobenzene; Erythema; Humans; Hypersensitivity, Delayed; Methods; N | 1979 |
[Theoretical principles of clinical tumor immunology].
Topics: Adsorption; Antigens, Neoplasm; BCG Vaccine; Cell Migration Inhibition; Cytotoxicity Tests, Immunolo | 1975 |
DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Dinitrochlorob | 1975 |
Cancer immunotherapy: an overview.
Topics: Adult; Aged; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; BCG Vaccine; Dinitroch | 1974 |
1 trial available for dinitrochlorobenzene and Neoplasms
Article | Year |
---|---|
Effect of short-term levamisole therapy on delayed hypersensitivity.
Topics: Adult; Aged; Clinical Trials as Topic; Dinitrochlorobenzene; Female; Humans; Hypersensitivity, Delay | 1980 |
48 other studies available for dinitrochlorobenzene and Neoplasms
Article | Year |
---|---|
The Interaction of Human Glutathione Transferase GSTA1-1 with Reactive Dyes.
Topics: Amino Acid Sequence; Anticarcinogenic Agents; Binding Sites; Coloring Agents; Dinitrochlorobenzene; | 2021 |
Multimodel pathway enrichment methods for functional evaluation of expression regulation.
Topics: Biosynthetic Pathways; Cell Line, Tumor; Computational Biology; Databases, Protein; Dinitrochloroben | 2012 |
Role of phagocytic cells in cancer.
Topics: Anaerobiosis; Antineoplastic Agents; Breast Neoplasms; Complement Activation; Dinitrochlorobenzene; | 1981 |
[Importance and limitations of the immunological monitoring of patients with malignant tumors].
Topics: Adult; Aged; Antibody Formation; Complement C3; Complement C4; Dinitrochlorobenzene; Humans; Immunit | 1984 |
Delayed-type hypersensitivity skin testing. A review.
Topics: Aged; Antigens, Fungal; Dinitrochlorobenzene; Histoplasmin; Histoplasmosis; Humans; Hypersensitivity | 1983 |
Cancer therapy--an immunological approach.
Topics: B-Lymphocytes; Dinitrochlorobenzene; Humans; Immunosuppression Therapy; Immunotherapy; Neoplasms; T- | 1982 |
[Morphological correlates of anti-tumor immunity. I. Reactions to dinitrochlorobenzene and tissue of autologous tumors].
Topics: Dinitrochlorobenzene; Humans; Immunity, Cellular; Neoplasms; Nitrobenzenes; Skin Tests | 1982 |
[The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes].
Topics: Aged; Dinitrochlorobenzene; Humans; Lymphocyte Activation; Middle Aged; Neoplasms; Nitrobenzenes; Ph | 1982 |
D.N.C.B. testing in cancer patients.
Topics: Dinitrochlorobenzene; Humans; Immunity, Cellular; Neoplasms; Nitrobenzenes; Skin Tests | 1982 |
Studies on the dinitrochlorobenzene (DNCB) sensitization test.
Topics: Adolescent; Adult; Aged; Child; Dinitrochlorobenzene; Female; Glucocorticoids; Humans; Lymphocyte Ac | 1982 |
Skin reactivity to dinitrochlorobenzene in cancer patients.
Topics: Adolescent; Adult; Aged; Dinitrochlorobenzene; Female; Humans; Male; Middle Aged; Neoplasms; Nitrobe | 1980 |
Immunity and cancer.
Topics: Antibody Formation; Antigens, Neoplasm; Antigens, Surface; Cell Membrane; Dinitrochlorobenzene; Huma | 1981 |
Skin sensitization with the new reagents NOPYE (4-nitro-1-cyclohexyl-3-ethoxy-2-oxo-3-pyrroline) and NOPY-L-phenylalanine.
Topics: Adjuvants, Immunologic; Animals; Cross Reactions; Cyclohexanes; Dinitrochlorobenzene; Female; Guinea | 1980 |
[Meaning of cellular immunity tests in neoplasms].
Topics: Dinitrochlorobenzene; Humans; Immunity, Cellular; Neoplasms; Tuberculin Test | 1980 |
Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dinitrochlorobenzene; Drug Hypersensitivity; Female; Glycopro | 1980 |
Unique immunobiological aspects of head and neck squamous carcinoma.
Topics: Antibody Formation; Antigen-Antibody Reactions; Carcinoma, Squamous Cell; Cells, Cultured; Complemen | 1975 |
Immunotherapy of malignancy in humans. Current status.
Topics: Adjuvants, Immunologic; Antigens, Neoplasm; BCG Vaccine; Carcinoma, Basal Cell; Carcinoma, Squamous | 1975 |
BCG administration and nursing implications.
Topics: Administration, Oral; BCG Vaccine; Cicatrix; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed | 1979 |
BCG in cancer therapy: theoretical bases of immunotherapy.
Topics: Antigens, Neoplasm; BCG Vaccine; Dinitrochlorobenzene; Humans; Immunity, Cellular; Immunotherapy; Ly | 1979 |
Tumor immunology and immunotherapy.
Topics: Antigens, Neoplasm; BCG Vaccine; Carcinoembryonic Antigen; Dinitrochlorobenzene; Gastrointestinal Ne | 1977 |
Immunologic testing as a guide to cancer management.
Topics: Antibody Formation; Antigen-Antibody Complex; Breast Neoplasms; Colonic Neoplasms; Complement System | 1979 |
[Delayed hypersensitivity intracutaneous test with dinitrochlorobenzene (DNCB)].
Topics: Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Neoplasms; Nitrobenzenes; Skin Tests | 1979 |
[The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Dinitrochlorobenzene; Female; Gastrointestinal Neoplasms | 1979 |
Immunocompetence testing in patients with one of the four common operable cancers--a review.
Topics: Breast Neoplasms; Colonic Neoplasms; Dinitrochlorobenzene; Female; Head and Neck Neoplasms; Humans; | 1978 |
Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.
Topics: Cyclophosphamide; Dinitrochlorobenzene; Fluorouracil; Humans; Immunity, Cellular; Methotrexate; Neop | 1978 |
Nonspecific antigen reactions.
Topics: Administration, Topical; Antibody Formation; Antigens; Antineoplastic Agents; BCG Vaccine; Breast Ne | 1976 |
Suppression of cellular immunity by anesthesia and operation.
Topics: Adenocarcinoma; Adult; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Intravenous; Carcino | 1977 |
Value of delayed hypersensitivity index in patients with malignancy.
Topics: Candida; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Mumps; Neoplas | 1977 |
Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Topics: Administration, Topical; Aged; Desensitization, Immunologic; Dinitrochlorobenzene; Drug Hypersensiti | 1977 |
Delayed hypersensitivity reaction: its relation to tumor spread and prognosis.
Topics: Antigens, Neoplasm; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Neo | 1977 |
[Some problems of immunological reactivity in patients with neoplasms].
Topics: Antigens, Neoplasm; Dinitrochlorobenzene; Humans; Immunity, Cellular; Neoplasm Proteins; Neoplasms; | 1976 |
Correlation between phytohemagglutinin skin test and delayed cutaneous hypersensitivity to dinitrochlorobenzene in cancer patients.
Topics: Adult; Aged; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Lectins; Liver Neoplasms; Lung | 1976 |
Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancer.
Topics: Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Neoplasm Metastasis; Neoplasm Recurrence, L | 1976 |
Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigens.
Topics: Adolescent; Adult; Aged; Antigen-Antibody Reactions; Antigens; Autoimmune Diseases; Carrier Proteins | 1975 |
Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
Topics: Adult; Aged; B-Lymphocytes; Dinitrochlorobenzene; Erythrocytes; Female; Humans; Hypersensitivity, De | 1976 |
A technique for intensifying BCG sensitivity.
Topics: Animals; BCG Vaccine; Dinitrochlorobenzene; Guinea Pigs; Hypersensitivity, Delayed; Immunity, Cellul | 1975 |
Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors.
Topics: Adenocarcinoma; Breast Neoplasms; Bronchial Neoplasms; Carcinoma, Squamous Cell; Dinitrochlorobenzen | 1975 |
The effect of radial radiotherapy on delayed hypersensitivity and the inflammatory response.
Topics: Animals; Croton Oil; Dinitrochlorobenzene; Hypersensitivity, Delayed; Immunity, Cellular; Inflammati | 1975 |
Lack of correlation between skin reactivity to dinitrochlorobenzene and croton oil in patients with cancer.
Topics: Croton Oil; Dinitrochlorobenzene; Humans; Immunity, Cellular; Neoplasms; Nitrobenzenes; Prognosis; S | 1975 |
Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival.
Topics: Adolescent; Adult; Aged; Dinitrochlorobenzene; Female; Genital Neoplasms, Female; Head; Head and Nec | 1975 |
Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. I. Hematologic and immunologic parameters in vivo.
Topics: Adult; Antigens; Blood Cell Count; Blood Platelets; Cell Separation; Dinitrochlorobenzene; Female; H | 1975 |
[Cellular immunity in the neoplastic patient (preliminary note)].
Topics: Dinitrochlorobenzene; Humans; Immunity, Cellular; Neoplasms; Skin Tests | 1975 |
[Use of immunologic tests in periodic preventive examinations of workers involved in benzidine production].
Topics: Adult; Aminobiphenyl Compounds; Antigens; Benzidines; Chemical Industry; Dinitrochlorobenzene; Embry | 1975 |
Immunologic impairment in patients with non-lymphoid cancer: correlation with the tumoral stage, response to treatment and survival.
Topics: Dinitrochlorobenzene; Humans; Immunity, Cellular; Lectins; Neoplasms; Prognosis; Skin Tests | 1976 |
Immunotherapy and human tumor immunology.
Topics: BCG Vaccine; Dinitrochlorobenzene; Immunity, Cellular; Immunotherapy; Leukemia; Neoplasms; Propionib | 1976 |
TMCHB: a possible alternative to DNCB in skin testing for immune competence.
Topics: Antigen-Antibody Reactions; Butanones; Dinitrochlorobenzene; Humans; Neoplasms; Patch Tests; Skin Te | 1988 |
Lymphocyte stimulation tests in cancer patients.
Topics: Adult; Carcinoma; Dinitrochlorobenzene; Humans; In Vitro Techniques; Leukocyte Count; Lymphocytes; M | 1973 |
Cutaneous reactivity in patients with cancer of the head and neck region.
Topics: Age Factors; Aged; Carcinoma, Squamous Cell; Croton Oil; Dinitrochlorobenzene; Drug Hypersensitivity | 1973 |